Could a weekly shot help tame type 1 diabetes?

NCT ID NCT06630585

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a weekly medicine called tirzepatide to usual insulin therapy helps adults with type 1 diabetes control their blood sugar better. About 42 people aged 18-65 who already use an automated insulin pump will take part. The goal is to see if the combination leads to more time with blood sugar in a healthy range.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • DiaCenTRE - Hirslanden Clinique des Grangettes

    RECRUITING

    Chêne-Bougeries, Canton of Geneva, 1224, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kantonsspital Olten

    RECRUITING

    Olten, Canton of Solothurn, 4600, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Luzerner Kantonspital

    RECRUITING

    Lucerne, 6000, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact